Geron (GERN) Receivables - Other (2010 - 2026)
Geron's (GERN) quarterly Receivables - Other came in at $2.2 million in Q1 2026, down 21.44% year-on-year from $2.8 million in Q1 2025, and down 1.16% quarter-over-quarter from $2.2 million in Q4 2025.
Geron (GERN) Receivables - Other (2010 - 2026) Analysis & Trends
Geron has disclosed Receivables - Other across 17 years of filings, most recently posting $2.2 million for Q1 2026.
- Receivables - Other for Q1 2026 came in at $2.2 million, down 21.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 21.44% YoY), and the FY2025 annual result was $2.2 million, down 21.52% from the prior year.
- Receivables - Other came in at $2.2 million for Q1 2026 at Geron, down from $2.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $22.2 million in Q3 2022 to a low of $1.2 million in Q2 2023.
- The 5-year median for Receivables - Other is $2.3 million (2025), against an average of $4.4 million.
- Across the five-year window, Receivables - Other surged 3543.11% in 2022 and plunged 85.89% in 2024, its largest moves.
- Geron's Receivables - Other stood at $3.1 million in 2022, then slumped by 47.36% to $1.7 million in 2023, then soared by 72.39% to $2.9 million in 2024, then slipped by 21.52% to $2.2 million in 2025, then retreated by 1.16% to $2.2 million in 2026.
- The last three Receivables - Other figures came in at $2.2 million (Q1 2026), $2.2 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.21 Mn |
| Mar 31, 2026 | 2.21 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Dec 31, 2023 | 1.66 Mn |